Enveric Biosciences Statistics
Total Valuation
ENVB has a market cap or net worth of $2.59 million. The enterprise value is -$517,722.
Important Dates
The next estimated earnings date is Tuesday, March 25, 2025, before market open.
| Earnings Date | Mar 25, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
ENVB has 1.91 million shares outstanding. The number of shares has increased by 167.86% in one year.
| Current Share Class | 1.91M |
| Shares Outstanding | 1.91M |
| Shares Change (YoY) | +167.86% |
| Shares Change (QoQ) | +14.70% |
| Owned by Insiders (%) | 0.98% |
| Owned by Institutions (%) | 3.61% |
| Float | 1.89M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.21 |
| P/TBV Ratio | 0.67 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.17
| Current Ratio | 5.17 |
| Quick Ratio | 3.73 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -308.65% and return on invested capital (ROIC) is -173.07%.
| Return on Equity (ROE) | -308.65% |
| Return on Assets (ROA) | -96.88% |
| Return on Invested Capital (ROIC) | -173.07% |
| Return on Capital Employed (ROCE) | -223.80% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.41M |
| Employee Count | 7 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, ENVB has paid $24,049 in taxes.
| Income Tax | 24,049 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -89.53% in the last 52 weeks. The beta is 0.19, so ENVB's price volatility has been lower than the market average.
| Beta (5Y) | 0.19 |
| 52-Week Price Change | -89.53% |
| 50-Day Moving Average | 4.17 |
| 200-Day Moving Average | 7.22 |
| Relative Strength Index (RSI) | 19.04 |
| Average Volume (20 Days) | 564,430 |
Short Selling Information
The latest short interest is 233,170, so 12.22% of the outstanding shares have been sold short.
| Short Interest | 233,170 |
| Short Previous Month | 407,352 |
| Short % of Shares Out | 12.22% |
| Short % of Float | 12.35% |
| Short Ratio (days to cover) | 1.01 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -8.84M |
| Pretax Income | -15.04M |
| Net Income | -9.86M |
| EBITDA | -8.50M |
| EBIT | -8.84M |
| Earnings Per Share (EPS) | -$26.17 |
Full Income StatementBalance Sheet
| Cash & Cash Equivalents | 3.11M |
| Total Debt | n/a |
| Net Cash | 3.11M |
| Net Cash Per Share | $1.63 |
| Equity (Book Value) | 3.95M |
| Book Value Per Share | 6.59 |
| Working Capital | 3.50M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$8.17 million and capital expenditures $15, giving a free cash flow of -$8.17 million.
| Operating Cash Flow | -8.17M |
| Capital Expenditures | 15 |
| Free Cash Flow | -8.17M |
| FCF Per Share | -$4.28 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |